Chemical formula: C₁₄H₁₉NO₂ Molecular mass: 233.306 g/mol PubChem compound: 4158
Methylphenidate is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Methylphenidate is indicated as part of a comprehensive treatment programme for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6-17 years old when remedial measures alone prove insufficient.
Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria or the guidelines in International Classification of Diseases, Tenth Revision (ICD-10) and should be based on a complete history and evaluation of the patient. Diagnosis cannot be made solely on the presence of one or more symptoms.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Methylphenidate is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.